Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TRAP markers and Zometa in lung cancer bone metastasis
NCT00265200Phase 2Terminated
- Sponsor
- University of Louisville
- Start
- Feb 2005
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zoledronic acid in bone metastases, sponsored by University of Louisville. Started Feb 2005; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
bone metastases
Beyond the preview
Go deeper on NCT00265200.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00265200.